Bausch Health Companies (TSE:BHC) Shares Down 8.8% – Here’s Why

Bausch Health Companies Inc. (TSE:BHC)’s stock price dropped 8.8% on Friday . The stock traded as low as C$8.11 and last traded at C$8.27. Approximately 366,705 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 394,074 shares. The stock had previously closed at C$9.07.

Analysts Set New Price Targets

BHC has been the subject of several analyst reports. Raymond James Financial upgraded Bausch Health Companies to a “hold” rating in a research report on Monday, December 15th. Barclays raised shares of Bausch Health Companies to a “hold” rating in a research note on Monday, December 8th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of “Hold”.

Bausch Health Companies Trading Down 10.0%

The business has a 50 day simple moving average of C$9.57 and a 200-day simple moving average of C$9.38. The stock has a market capitalization of C$3.02 billion, a price-to-earnings ratio of 8.41, a PEG ratio of 0.21 and a beta of 0.54. The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings results on Wednesday, October 29th. The company reported C$0.48 EPS for the quarter. Bausch Health Companies had a positive return on equity of 15.87% and a negative net margin of 1.88%.The company had revenue of C$2.68 billion for the quarter. As a group, equities analysts expect that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.